Food for Thought
February 12, 2020
If we learn more about drug–nutrient interactions, we may be on the path towards better medicines
0 min read
Welcome to the January issue! There will be another recession – as certain as night follows day – but, our cover feature asks, how bad will it be? And is the pharma industry prepared? In Upfront, we explore how digital tech is fighting fake medicine, and how computer simulations are improving ADC linkers. Araksya Topchyan highlights the importance of drug-nutrient interactions in In My View; while NextGen asks: what happens if you try to apply open source to pharmaceutical R&D? Last but not least, we Sit Down With Jane Osbourn, Chair at Mogrify and the UK BioIndustry Association.
February 12, 2020
If we learn more about drug–nutrient interactions, we may be on the path towards better medicines
0 min read
February 5, 2020
Acquisitions, market growth and global trends… We examine what’s going on in pharmaceutical packaging.
0 min read
February 4, 2020
How can pharmaceutical packaging be adapted to meet patient and supply chain requirements?
0 min read
February 3, 2020
Time to mine the biologically active compounds of fungi
0 min read
January 29, 2020
How digital technologies are helping to secure the pharmaceutical supply chain
0 min read
January 29, 2020
Attempting to curb antibioitc resistance, researchers at RMIT Univeristy, Melbourne, Australia, have developed a technique using liquid metals to shred bacteria, preventing them from thriving without harming normal cells.
0 min read
January 28, 2020
3D-printed water-in-water constructs mimic cell compartmentalization with potential in drug delivery
0 min read
January 27, 2020
The pharmaceutical industry must be encouraged to look beyond patients in advanced economies to all patients who could benefit from innovative medicines, no matter where they live
0 min read
January 23, 2020
The US will have another recession – as certain as night follows day – but how bad will it be? And is the pharmaceutical industry prepared?
0 min read
January 22, 2020
Open source platforms have transformed software development and led to lower costs for consumers. What would happen if pharmaceutical R&D applied a similar approach?
0 min read
January 21, 2020
Cures for all presents a real focus for the next decade – but companies must be rewarded for their work
0 min read
January 20, 2020
How to design more stable and predictable antibody-drug conjugates
0 min read
January 15, 2020
Advances in manufacturing aren’t enough to overcome the challenge of poorly soluble APIs – we must also embrace novel approaches to excipients
0 min read
January 15, 2020
Sitting Down With… Jane Osbourn, Chair at Mogrify and the UK BioIndustry Association, Cambridge, UK
0 min read
January 14, 2020
Recent years have seen renewed interest in inhaled drug delivery. We take a deep dive into inhaled formulations with Lei Mao, Director of Inhalation Science and Product Development at Recipharm Laboratories
0 min read
False
False